|
[1]
|
Kolodziejczyk, A.A., Zheng, D., Shibolet, O. and Elinav, E. (2019) The Role of the Microbiome in NAFLD and NASH. EMBO Molecular Medicine, 11, Article No. 9302. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Guan, M., Wang, M., Liu, S., Ouyang, W., Liang, L., Pawlik, T.M., et al. (2021) Early Diagnosis and Therapeutic Strategies for Hepatocellular Carcinoma: From Bench to Bedside. World Journal of Gastrointestinal Oncology, 13, 197-215. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Morishita, A., Oura, K., Tadokoro, T., Fujita, K., Tani, J., Kobara, H., et al. (2023) MicroRNAs and Nonalcoholic Steatohepatitis: A Review. International Journal of Molecular Sciences, 24, Article 14482. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Povsic, M., Wong, O.Y., Perry, R. and Bottomley, J. (2019) A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH). Advances in Therapy, 36, 1574-1594. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Pinter, M., Pinato, D.J., Ramadori, P. and Heikenwalder, M. (2022) NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy. Clinical Cancer Research, 29, 513-520. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Thomas, J.A., Kendall, B.J., Dalais, C., Macdonald, G.A. and Thrift, A.P. (2022) Hepatocellular and Extrahepatic Cancers in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. European Journal of Cancer, 173, 250-262. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wattacheril, J., Issa, D. and Sanyal, A. (2018) Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies. Annual Review of Pharmacology and Toxicology, 58, 649-662. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Møllerhøj, M.B., Veidal, S.S., Thrane, K.T., Oró, D., Overgaard, A., Salinas, C.G., et al. (2022) Hepatoprotective Effects of Semaglutide, Lanifibranor and Dietary Intervention in the GAN Diet‐Induced Obese and Biopsy‐Confirmed Mouse Model of Nash. Clinical and Translational Science, 15, 1167-1186. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Rinella, M.E., Elias, M.S., Smolak, R.R., Fu, T., Borensztajn, J. and Green, R.M. (2008) Mechanisms of Hepatic Steatosis in Mice Fed a Lipogenic Methionine Choline-Deficient Diet. Journal of Lipid Research, 49, 1068-1076. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Caballero, F., Fernández, A., De Lacy, A.M., Fernández-Checa, J.C., Caballería, J. and García-Ruiz, C. (2009) Enhanced Free Cholesterol, SREBP-2 and Star Expression in Human Nash. Journal of Hepatology, 50, 789-796. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Feldstein, A.E. and Bailey, S.M. (2011) Emerging Role of Redox Dysregulation in Alcoholic and Nonalcoholic Fatty Liver Disease. Antioxidants & Redox Signaling, 15, 421-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Loomba, R., Friedman, S.L. and Shulman, G.I. (2021) Mechanisms and Disease Consequences of Nonalcoholic Fatty Liver Disease. Cell, 184, 2537-2564. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
黄樱硕, 魏巍, 佟小非, 等. 非酒精性脂肪性肝炎新药临床试验方案的系统评价[J]. 临床肝胆病杂志, 2022, 38(4): 798-804.
|
|
[14]
|
Younossi, Z.M., Corey, K.E. and Lim, J.K. (2021) AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology, 160, 912-918. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Islam, M.S., Miao, L., Yu, H., Han, Z. and Sun, H. (2019) Ethanol Extract of Illicium Henryi Attenuates LPS-Induced Acute Kidney Injury in Mice via Regulating Inflammation and Oxidative Stress. Nutrients, 11, Article No. 1412. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zhang, C., Sheng, J., Sarsaiya, S., Shu, F., Liu, T., Tu, X., et al. (2019) The Anti-Diabetic Activities, Gut Microbiota Composition, the Anti-Inflammatory Effects of Scutellaria-Coptis Herb Couple against Insulin Resistance-Model of Diabetes Involving the Toll-Like Receptor 4 Signaling Pathway. Journal of Ethnopharmacology, 237, 202-214. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
熊静平, 张跃新. 抑制脯氨酰内肽酶表达对非酒精性脂肪性肝炎小鼠模型的影响及作用机制[J]. 临床肝胆病杂志, 2025, 41(6): 1097-1104.
|
|
[18]
|
吴永保, 唐静, 闻治国, 等. 蛋氨酸对HepG2细胞和鸭原代肝细胞生长和脂质代谢的影响[J]. 动物营养学报, 2022, 34(8): 5364-5373.
|
|
[19]
|
杨海琳, 张定棋, 陈高峰, 等. 蛋氨酸-胆碱缺乏饮食诱导代谢相关脂肪肝模型小鼠血清和肝脏胆汁酸谱的变化[J]. 中国组织工程研究, 2021, 25(26): 4137-4144.
|